Literature DB >> 30559479

Invasion of white matter tracts by glioma stem cells is regulated by a NOTCH1-SOX2 positive-feedback loop.

Jun Wang1,2, Sen-Lin Xu1, Jiang-Jie Duan1,2, Liang Yi3, Yu-Feng Guo1,2, Yu Shi1, Lin Li1,2, Ze-Yu Yang1,2, Xue-Mei Liao1,2, Jiao Cai1,2, Yan-Qi Zhang4, Hua-Liang Xiao5, Li Yin1,2, Hao Wu6, Jing-Na Zhang7, Sheng-Qing Lv8, Qing-Kai Yang9, Xiao-Jun Yang10, Tao Jiang11, Xia Zhang1, Xiu-Wu Bian12, Shi-Cang Yu13,14.   

Abstract

Early invasive growth along specific anatomical structures, especially the white matter tract, is regarded as one of the main causes of poor therapeutic outcome of people with gliomas. We show that some glioma stem cells (GSCs) are preferentially located along white matter tracts, which exhibit a demyelinated phenotype, at the invasive frontier of glioma tissues. These GSCs are CD133+Notch1+, whereas the nerve fibers express the Notch ligand Jagged1. The Notch-induced transcription factor Sox9 promotes the transcription of SOX2 and the methylation level of the NOTCH1 promoter is attenuated by the upregulation of SOX2 to reinforce NOTCH1 expression in GSCs. This positive-feedback loop in a cohort of glioma subjects is correlated with a poor prognosis. Inhibition of Notch signaling attenuates the white-matter-tract tropism of GSCs. These findings provide evidence indicating that the NOTCH1-SOX2 positive-feedback loop controls GSC invasion along white matter tracts.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30559479     DOI: 10.1038/s41593-018-0285-z

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  2 in total

1.  Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.

Authors:  Daniel V Brown; Paul M Daniel; Giovanna M D'Abaco; Andrew Gogos; Wayne Ng; Andrew P Morokoff; Theo Mantamadiotis
Journal:  Oncotarget       Date:  2015-03-20

Review 2.  Notching on Cancer's Door: Notch Signaling in Brain Tumors.

Authors:  Marcin Teodorczyk; Mirko H H Schmidt
Journal:  Front Oncol       Date:  2015-01-05       Impact factor: 6.244

  2 in total
  44 in total

1.  Glioblastomas exploit truncated O-linked glycans for local and distant immune modulation via the macrophage galactose-type lectin.

Authors:  Sophie A Dusoswa; Jan Verhoeff; Erik Abels; Santiago P Méndez-Huergo; Diego O Croci; Lisan H Kuijper; Elena de Miguel; Valerie M C J Wouters; Myron G Best; Ernesto Rodriguez; Lenneke A M Cornelissen; Sandra J van Vliet; Pieter Wesseling; Xandra O Breakefield; David P Noske; Thomas Würdinger; Marike L D Broekman; Gabriel A Rabinovich; Yvette van Kooyk; Juan J Garcia-Vallejo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-04       Impact factor: 11.205

2.  Dissecting and rebuilding the glioblastoma microenvironment with engineered materials.

Authors:  Kayla J Wolf; Joseph Chen; Jason Coombes; Manish K Aghi; Sanjay Kumar
Journal:  Nat Rev Mater       Date:  2019-08-16       Impact factor: 66.308

3.  The distribution of liver cancer stem cells correlates with the mechanical heterogeneity of liver cancer tissue.

Authors:  Yuchuan Sun; Hong Li; Qiufang Chen; Qing Luo; Guanbin Song
Journal:  Histochem Cell Biol       Date:  2021-03-12       Impact factor: 4.304

Review 4.  Metabolic heterogeneity and adaptability in brain tumors.

Authors:  Christian E Badr; Daniel J Silver; Florian A Siebzehnrubl; Loic P Deleyrolle
Journal:  Cell Mol Life Sci       Date:  2020-06-06       Impact factor: 9.261

5.  Conventional Treatment of Glioblastoma Reveals Persistent CD44+ Subpopulations.

Authors:  Johann Mar Gudbergsson; Esben Christensen; Serhii Kostrikov; Torben Moos; Meg Duroux; Andreas Kjær; Kasper Bendix Johnsen; Thomas Lars Andresen
Journal:  Mol Neurobiol       Date:  2020-07-06       Impact factor: 5.590

Review 6.  Pineal Gland Tumor Microenvironment.

Authors:  Joham Choque-Velasquez; Szymon Baluszek; Roberto Colasanti; Sajjad Muhammad; Juha Hernesniemi
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

7.  LncRNA CCAT2 promotes angiogenesis in glioma through activation of VEGFA signalling by sponging miR-424.

Authors:  Sheng-Li Sun; Yu-Gao Shu; Mei-Yi Tao
Journal:  Mol Cell Biochem       Date:  2020-04-01       Impact factor: 3.396

8.  TRIM24 promotes stemness and invasiveness of glioblastoma cells via activating Sox2 expression.

Authors:  Lu-Hua Zhang; Yi-Heng Yin; Hong-Zun Chen; Shi-Yu Feng; Jia-Lin Liu; Ling Chen; Wen-Liang Fu; Guo-Chen Sun; Xin-Guang Yu; Dong-Gang Xu
Journal:  Neuro Oncol       Date:  2020-12-18       Impact factor: 12.300

9.  Immune Checkpoint-Associated Locations of Diffuse Gliomas Comparing Pediatric With Adult Patients Based on Voxel-Wise Analysis.

Authors:  Li Zhang; Buyi Zhang; Zhangqi Dou; Jiawei Wu; Yasaman Iranmanesh; Biao Jiang; Chongran Sun; Jianmin Zhang
Journal:  Front Immunol       Date:  2021-03-17       Impact factor: 7.561

10.  Oncolytic HSV-Infected Glioma Cells Activate NOTCH in Adjacent Tumor Cells Sensitizing Tumors to Gamma Secretase Inhibition.

Authors:  Yoshihiro Otani; Ji Young Yoo; Samantha Chao; Joseph Liu; Alena Cristina Jaime-Ramirez; Tae Jin Lee; Brian Hurwitz; Yuanqing Yan; Hongsheng Dai; Joseph C Glorioso; Michael A Caligiuri; Jianhua Yu; Balveen Kaur
Journal:  Clin Cancer Res       Date:  2020-03-05       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.